232 related articles for article (PubMed ID: 17168346)
1. The role of BNP testing in heart failure.
Doust J; Lehman R; Glasziou P
Am Fam Physician; 2006 Dec; 74(11):1893-8. PubMed ID: 17168346
[TBL] [Abstract][Full Text] [Related]
2. [Natriuretic peptides--new diagnostic markers in heart disease].
Angermann CE; Ertl G
Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
4. [Brain natriuretic Peptide. Diagnostic and prognostic value in chronic heart failure].
Krüger S; Hoffmann R; Graf J; Janssens U; Hanrath P
Med Klin (Munich); 2003 Oct; 98(10):562-7. PubMed ID: 14586510
[TBL] [Abstract][Full Text] [Related]
5. Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.
Yamaji M; Tsutamoto T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
Circ Heart Fail; 2009 Nov; 2(6):608-15. PubMed ID: 19919986
[TBL] [Abstract][Full Text] [Related]
6. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
[TBL] [Abstract][Full Text] [Related]
8. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].
Pascual-Figal DA; Peñafiel P; Nicolas F; de la Morena G; Ansaldo P; Redondo B; Sánchez Mas J; Valdés M
Rev Esp Cardiol; 2008 Mar; 61(3):260-8. PubMed ID: 18361899
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic and prognostic value of B-type natriuretic peptides in heart failure or signs of heart failure].
Rutten JH; Boomsma F; Van den Meiracker AH
Ned Tijdschr Geneeskd; 2007 Nov; 151(46):2553-7. PubMed ID: 18074722
[TBL] [Abstract][Full Text] [Related]
11. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.
Omland T
Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473
[TBL] [Abstract][Full Text] [Related]
12. [Brain natriuretic peptide and QRS duration as a predictor for cardiac events in patients with heart failure].
Taniguchi T; Kawasaki T; Miyai N; Kamitani T; Kawasaki S; Sugihara H
J Cardiol; 2006 Jun; 47(6):277-83. PubMed ID: 16800370
[TBL] [Abstract][Full Text] [Related]
13. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
14. [BNP measurement for perioperative management].
Ishiguro T; Gyouda Y; Yoshizawa A; Arakawa K
Masui; 2009 May; 58(5):604-8. PubMed ID: 19462798
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic impact of brain natriuretic peptide in cardiac and noncardiac diseases.
Zakynthinos E; Kiropoulos T; Gourgoulianis K; Filippatos G
Heart Lung; 2008; 37(4):275-85. PubMed ID: 18620103
[TBL] [Abstract][Full Text] [Related]
17. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
18. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
Januzzi JL; Chen-Tournoux AA; Moe G
Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
[TBL] [Abstract][Full Text] [Related]
19. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
[TBL] [Abstract][Full Text] [Related]
20. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
Miller WL; Hartman KA; Burritt MF; Grill DE; Rodeheffer RJ; Burnett JC; Jaffe AS
Circulation; 2007 Jul; 116(3):249-57. PubMed ID: 17592074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]